Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells
Cell therapy for patients who have intractable muscle disorders may require highly regenerative cells from young, healthy allogeneic donors. Mesenchymal stem cells are currently under clinical investigation because they are known to induce muscle regeneration and believed to be immune privileged, th...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2014-02-01
|
| Series: | Journal of Tissue Engineering |
| Online Access: | https://doi.org/10.1177/2041731414524758 |